<h1>Recommendation pertains to infection risk and does not account for risk of cardiac events or venous thromboembolism.</h1>

<h1>RESULTS/RECOMMENDATIONS</h1>

<h1>Table 3. Recommendations for perioperative management of anti-rheumatic drug therapy in patients with inflammatory arthritis and those with systemic lupus erythematosus (SLE) undergoing elective total hip arthroplasty (THA) or total knee arthroplasty (TKA)*</h1>